We are interested in how environmental cues control the choice between dauer arrest and growth. We study a group of TGF-beta pathway related genes that control this process. Research performed in the labs of Don Riddle and Jim Thomas led to the cloning of genes that are homologous to TGF-beta pathways in other systems (see Fig. 1). These include
daf-7 (a TGF-beta ligand),
daf-1 and
daf-4 (serine/threonine kinase receptors), and
daf-8 and
daf-14, which are homologous to the Smad family of transcription factors. Smads have been shown to be regulated by phosphorylation by the receptors in other systems. Mutations in these genes have a dauer constitutive phenotype. We have cloned the
daf-3 gene, which has a dauer defective mutant phenotype that is epistatic to the dauer constitutive mutants.
daf-3, like
daf-8 and
daf-14, is homologous to the Smad family of transcription factors. The fact that
daf-3 is epistatic to
daf-8 and
daf-14 suggests a model in which the DAF-3 protein is negatively regulated by DAF-8 and DAF-14. In other systems, Smads proteins interact and regulate each other. We are interested in determining whether the DAF-3 protein interacts with the DAF-8 and DAF-14 proteins, and will discuss plans to study these interactions in protein extracts from C. elegans and in yeast two-hybrid experiments. In our model, the receptors function only to negatively regulate DAF-3 via DAF-8 and DAF-14. This model suggests that, unlike most Smads, DAF-3 is functional as a transcription factor without requiring phosphorylation by an upstream receptor. We will discuss experiments performed by Chang Yeol in Malcolm Whitman's lab that suggests that DAF-3 can mimic an activated Smad in Xenopus embyos. This line of experiments may allow us to verify that DAF-3 is a functional transcription factor in the absence of coupling to a receptor. In addition, we can use this system to test whether DAF-8 and DAF-14 block dauer formation by binding to DAF-3. We have isolated additional mutations that, like
daf-3, suppress the dauer constitutive phenotype of mutations in the TGF-beta pathway genes. We are pursuing cloning these suppressors, which may be cofactors of DAF-3, may represent positive regulators of DAF-3 function, or may represent other genes negatively regulated by the TGF-beta pathway. Figure 1: Model for regulation of DAF-3 by a TGF-beta pathway.